Beta Bionics, Inc. (NASDAQ: BBNX) reported Q4 EPS of ($0.30), $0.08 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $32.1 million.

For earnings history and earnings-related data on Beta Bionics, Inc. (BBNX) click here.